drugset / Trial / NCT00328874
Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy
Phase 2
Completed
20 enrolled
German Parkinson Study Group (GPS)
MSE Pharmazeutika GmbH, Louisenstr.114D-61348 Bad Homburg, Germany · collabPhilipps University Marburg · collabPitzer Stiftung · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study hypothesis: A 6-week p.o treatment with 5 mg/Kg Coenzyme Q10 is safe and tolerable,increases the brain's metabolism and ameliorates clinical symptoms in patients with PSP.
Timeline
- Start
- 2006-05
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Coenzyme Q10 | Other / unclassified | 5 mg/kg | Oral |